Healthcare
Protalix BioTherapeutics, Inc. (PLX)
68/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $179M
- P/E
- 11.8
- Sector Median P/E
- 24.4
- F-Score
- 5/9
- ROIC
- 24.0%
- FCF Yield
- 8.2%
Tessera scores PLX (Protalix BioTherapeutics, Inc.) at 68/100 — top 50% of the Healthcare sector. PLX trades at a P/E of 11.8, 52% below the sector median of 24.4. Piotroski F-Score is 5/9; trailing ROIC is 24.0%.
Sector Peers
- Vertex Pharmaceuticals Incorporated (VRTX)Mkt Cap: $114.6B · FCF: 30.3%
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- Regeneron Pharmaceuticals, Inc. (REGN)Mkt Cap: $62.8B · FCF: 27.9%
- argenx SE (ARGX)Mkt Cap: $54.3B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%